This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Peptides & Oligonucleotides

Addressing Complex Oligonucleotide Therapeutics and Approach Towards Endotoxin Removal

Posted by on 21 June 2023
Share this article

Carter Holt, Process Development Supervisor at Axolabs, discusses the importance of removing endotoxins from biological solutions at the TIDES USA conference in San Diego, Calif. In this interview, Holt highlights the potential points of endotoxin introduction during the manufacturing process and discusses Axolabs’ approaches, including the use of charged filters, SEC chromatography, and ultrafiltration, for efficient endotoxin removal.

Share this article